BIO-TECHNE Corp — insider transactions
9 transactions on record · TECH · CIK 842023
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
9
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$10.4M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$3.7M
2026-07-29
Director share, 12m
33.3%
of transactions where role is stated
Current run
9 sells
consecutive same-direction transactions
Net 3m flow
-$10.4M
purchases minus sales
Total on record
9
Transactions
9 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 2026-07-29 | 2 | Hippel James | CFO | Exercise of derivative | 62,068 | $47.60 | $3M | filing |
| 2026-07-31 | 2026-07-29 | 2 | Hippel James | CFO | Exercise of derivative | 62,068 | $0.00 | — | filing |
| 2026-07-31 | 2026-07-29 | 2 | Hippel James | CFO | Shares withheld for tax | 51,024 | $72.03 | $3.7M | filing |
| 2026-07-30 | 2026-07-28 | 2 | Kelderman Kim | Director, Chief Executive Officer | Exercise of derivative | 35,000 | $47.60 | $1.7M | filing |
| 2026-07-30 | 2026-07-28 | 2 | Kelderman Kim | Director, Chief Executive Officer | Shares withheld for tax | 28,686 | $72.07 | $2.1M | filing |
| 2026-07-30 | 2026-07-28 | 2 | Kelderman Kim | Director, Chief Executive Officer | Exercise of derivative | 35,000 | $0.00 | — | filing |
| 2026-07-27 | 2026-07-23 | 4 | Bohnen Shane | SVP - General Counsel | Exercise of derivative | 448 | $47.60 | $21.3K | filing |
| 2026-07-27 | 2026-07-23 | 4 | Bohnen Shane | SVP - General Counsel | Exercise of derivative | 448 | $0.00 | — | filing |
| 2026-07-27 | 2026-07-23 | 4 | Bohnen Shane | SVP - General Counsel | Shares withheld for tax | 344 | $71.77 | $24.7K | filing |